Transgenic animal expressing non-native wild-type and familial alzheimer's disease mutant presenilin 1 protein on native presenilin 1 null background
CA 2290039 A1 · Owner: Zheng, Hui · Inventors: Van Der Ploeg, Leonardus H.T.; Wong, Philip C.; Qian, Su
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to a transgenic non-human animal embryo laking native presenilin (1) and a transgenic non-human animal having only a nonnative presenilin (1). The transgenic animals and cells derived therefrom can be used in the study of the expression pattern activity and modulators of , presenilin (1) in the study of the role of presenilin (1) in Alzheimer's Disease and in the study of disorders of the central nervous system.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 13, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended May 13, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 13, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.